These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22158681)

  • 1. The final phase of polio eradication: new vaccines and complex choices.
    Cochi SL; Linkins RW
    J Infect Dis; 2012 Jan; 205(2):169-71. PubMed ID: 22158681
    [No Abstract]   [Full Text] [Related]  

  • 2. The final stages of the global eradication of polio.
    John TJ
    N Engl J Med; 2000 Sep; 343(11):806-7. PubMed ID: 10984572
    [No Abstract]   [Full Text] [Related]  

  • 3. Achieving and maintaining polio eradication--new strategies.
    Modlin J; Wenger J
    N Engl J Med; 2014 Oct; 371(16):1476-9. PubMed ID: 25317869
    [No Abstract]   [Full Text] [Related]  

  • 4. WHO policy statement on polio vaccines.
    Wkly Epidemiol Rec; 1995 Dec; 70(49):346-7. PubMed ID: 8652353
    [No Abstract]   [Full Text] [Related]  

  • 5. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines.
    McBean AM; Thoms ML; Albrecht P; Cuthie JC; Bernier R
    Am J Epidemiol; 1988 Sep; 128(3):615-28. PubMed ID: 2843039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus vaccines.
    Racaniello VR
    Biotechnology; 1992; 20():205-22. PubMed ID: 1318134
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possible method of eradication of poliomyelitis as an infection].
    Seĭbil' VB; Malyshkina LP
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (3):107-13. PubMed ID: 22830285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polio vaccines: WHO position paper – March, 2016.
    Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of poliomyelitis: a continuing paradox.
    Horstmann DM
    J Infect Dis; 1982 Oct; 146(4):540-51. PubMed ID: 6288809
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial.
    Liao G; Li R; Li C; Sun M; Li Y; Chu J; Jiang S; Li Q
    J Infect Dis; 2012 Jan; 205(2):237-43. PubMed ID: 22158682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New poliovirus vaccine schedules.
    Zhang Q; Leppold C; Shao Y; Mura Y; Tanimoto T
    Lancet; 2016 Nov; 388(10059):2477-2478. PubMed ID: 27871742
    [No Abstract]   [Full Text] [Related]  

  • 13. Polio vaccines: WHO position paper, January 2014.
    Wkly Epidemiol Rec; 2014 Feb; 89(9):73-92. PubMed ID: 24707513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Poliovirus immunology: vaccines, problems for the prevention/eradication and future interventions].
    Fernández-Cruz Pérez E; Rodríguez-Sainz C
    Rev Esp Salud Publica; 2013; 87(5):443-54. PubMed ID: 24322281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995-2014.
    Shaghaghi M; Shahmahmoodi S; Abolhassani H; Soleyman-Jahi S; Parvaneh L; Mahmoudi S; Chavoshzadeh Z; Yazdani R; Zahraei SM; Ebrahimi M; Eslamian MH; Tabatabaie H; Yousefi M; Kandelousi YM; Oujaghlou A; Rezaei N; Aghamohammadi A
    Emerg Infect Dis; 2016 Oct; 22(10):1712-9. PubMed ID: 27648512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Oral Polio Vaccine Safely Induces Antibodies Among Vaccine-Naive Infants.
    Slomski A
    JAMA; 2023 Jan; 329(4):279. PubMed ID: 36692562
    [No Abstract]   [Full Text] [Related]  

  • 18. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polio eradication: the endgame.
    Nat Med; 2001 Feb; 7(2):131. PubMed ID: 11175817
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014-2017.
    Grassly NC; Wadood MZ; Safdar RM; Mahamud AS; Sutter RW
    Emerg Infect Dis; 2018 Nov; 24(11):2113-2115. PubMed ID: 30252646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.